| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 19.49B | 18.54B | 16.75B | 22.36B | 28.80B | 17.30B |
| Gross Profit | 3.34B | 3.28B | 2.68B | 5.09B | 9.80B | 4.71B |
| EBITDA | 2.99B | 2.94B | 2.37B | 4.29B | 9.20B | 4.33B |
| Net Income | 1.53B | 1.33B | 907.40M | 1.91B | 6.78B | 2.80B |
Balance Sheet | ||||||
| Total Assets | 24.93B | 23.11B | 23.56B | 24.30B | 29.82B | 26.38B |
| Cash, Cash Equivalents and Short-Term Investments | 3.22B | 3.46B | 3.71B | 3.87B | 3.32B | 5.84B |
| Total Debt | 4.47B | 3.28B | 4.45B | 4.40B | 2.72B | 1.16B |
| Total Liabilities | 9.96B | 7.74B | 8.59B | 9.23B | 10.76B | 11.99B |
| Stockholders Equity | 14.94B | 15.34B | 14.95B | 15.05B | 19.04B | 14.33B |
Cash Flow | ||||||
| Free Cash Flow | 1.30B | 1.93B | 197.12M | 3.37B | 3.94B | 2.18B |
| Operating Cash Flow | 2.08B | 2.71B | 823.72M | 5.53B | 6.03B | 2.91B |
| Investing Cash Flow | -1.57B | -809.93M | -739.33M | -2.33B | -2.32B | 3.30B |
| Financing Cash Flow | -1.76B | -1.93B | -1.32B | -3.14B | -6.34B | -3.71B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | HK$3.24B | 11.70 | 8.69% | 3.25% | 19.25% | -10.14% | |
74 Outperform | HK$61.99B | 16.86 | 15.61% | 5.22% | 12.80% | 26.26% | |
67 Neutral | HK$2.76B | 1.00 | 93.70% | 46.02% | 12.26% | 2497.49% | |
66 Neutral | HK$2.54B | 20.59 | 6.63% | 1.01% | 46.98% | 130.04% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
60 Neutral | HK$2.88B | 12.09 | 2.88% | 9.26% | 2.59% | 0.23% | |
59 Neutral | HK$9.24B | 6.18 | 9.13% | 3.00% | 17.21% | 166.36% |